Happy Diwali
from all of us at RetailBonds
CRISIL · 2026-10-29
CRISIL withdraws rating on Mankind Pharma Limited — 29 Oct 2026
CRISIL withdrew its rating on Mankind Pharma Limited on 2026-10-29, rating AA+ with a Stable outlook. 1 bond on file is tied to this entity.
CRISIL's published heading: “Rating reaffirmed at ‘Crisil AA+/Stable’; Commercial Paper Withdrawn”
| Entity (per CRISIL heading) | Mankind Pharma Limited · issuer page |
| Action | Withdrawal |
| Rating | AA+ |
| Outlook | Stable |
| Action date | 2026-10-29 |
| Agency | CRISIL |
| Source | CRISIL rating rationale ↗ |
| Bond | Coupon | Maturity |
|---|---|---|
| Mankind Pharma 7.97% Nov 2027 NCD | 7.97% | 2027-11-16 |
About this page: This page restates a rating action as published by CRISIL, a SEBI-registered credit rating agency. The rating and any outlook are the agency's opinion, not RetailBonds.in's, and nothing here is investment advice or a view on what the action means for any investor. Refer to the agency's own rationale document for the full reasoning. See our methodology and full disclaimer.